Stonepine Capital Management, LLC - Significant Ownership

Signature - Title
/s/ Jon M. Plexico - Managing Member
Location
Bend, OR
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Stonepine Capital Management, LLC.

Significant Ownership of Stonepine Capital Management, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AYTU AYTU BIOPHARMA, INC Common Stock 9.9% $2.09M 906K Stonepine Capital Management, LLC Jun 30, 2025
EDSA Edesa Biotech, Inc. Common Stock 9.9% $1.6M 694K Stonepine Capital Management, LLC Feb 13, 2025
OPTN OptiNose, Inc. Common Stock 7.8% $7.1M $1.8M 789K +34% Stonepine Capital Management, LLC Mar 31, 2025
TELA TELA Bio, Inc. Common Stock 6% $2.42M 2.35M Stonepine Capital Management, LLC Dec 31, 2024
SRZN Surrozen, Inc./DE Common Stock 5.8% $5.94M $2.06M 509K +53% Stonepine Capital Management, LLC Jun 30, 2025
CNSP CNS Pharmaceuticals, Inc. Common Stock 5.6% $290K 32.2K Stonepine Capital Management, LLC Oct 29, 2025
KZR Kezar Life Sciences, Inc. Common Stock 5.2% $1.49M 377K Stonepine Capital Management, LLC Sep 2, 2025
CALC CalciMedica, Inc. Common Stock 4.6% $993K -$179K 629K -15.2% Stonepine Capital Management, LLC Mar 31, 2025
VSTM Verastem, Inc. Common Stock 4.3% $23.6M -$1.44M 2.67M -5.76% Stonepine Capital Management, LLC Sep 30, 2025
APRE Aprea Therapeutics, Inc. Common Stock 4.3% $488K -$95.8K 239K -16.4% Stonepine Capital Management, LLC Mar 31, 2025
INO Inovio Pharmaceuticals, Inc. Common Stock 3.8% $2.31M -$775K 1.43M -25.1% Stonepine Capital Management, LLC Mar 31, 2025

Schedules 13D/G Reported by Stonepine Capital Management, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.